Ameritas Investment Partners, Inc. - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 90 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$13,000
-40.9%
5,0100.0%0.00%
-100.0%
Q4 2021$22,000
-15.4%
5,0100.0%0.00%0.0%
Q3 2021$26,000
-18.8%
5,0100.0%0.00%0.0%
Q2 2021$32,000
-17.9%
5,0100.0%0.00%0.0%
Q1 2021$39,000
+62.5%
5,010
+35.8%
0.00%0.0%
Q4 2020$24,000
-4.0%
3,6890.0%0.00%0.0%
Q3 2020$25,000
-19.4%
3,6890.0%0.00%0.0%
Q2 2020$31,000
+10.7%
3,6890.0%0.00%
-50.0%
Q1 2020$28,000
-9.7%
3,6890.0%0.00%
+100.0%
Q4 2019$31,000
+14.8%
3,6890.0%0.00%0.0%
Q3 2019$27,000
-34.1%
3,6890.0%0.00%
-50.0%
Q2 2019$41,000
+2.5%
3,6890.0%0.00%0.0%
Q1 2019$40,000
-18.4%
3,689
+13.9%
0.00%
-33.3%
Q4 2018$49,000
-18.3%
3,2390.0%0.00%0.0%
Q3 2018$60,000
-18.9%
3,2390.0%0.00%
-25.0%
Q2 2018$74,000
+1.4%
3,239
+27.0%
0.00%0.0%
Q1 2018$73,000
+35.2%
2,5500.0%0.00%
+100.0%
Q4 2017$54,000
+22.7%
2,5500.0%0.00%0.0%
Q3 2017$44,000
+10.0%
2,5500.0%0.00%0.0%
Q2 2017$40,000
+48.1%
2,550
+60.3%
0.00%
+100.0%
Q1 2017$27,0001,5910.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
BVF INC/IL 5,803,700$25,130,0000.91%
Altium Capital Management LP 663,800$2,874,0000.79%
Rubric Capital Management LP 2,406,449$10,420,0000.49%
RTW INVESTMENTS, LP 6,029,700$26,109,0000.38%
Orbimed Advisors 3,214,509$13,919,0000.18%
TANG CAPITAL MANAGEMENT LLC 152,345$660,0000.13%
PLATINUM INVESTMENT MANAGEMENT LTD 980,085$4,244,0000.12%
Point72 Asset Management, L.P. 6,303,025$27,292,0000.11%
Sender Co & Partners, Inc. 40,720$176,0000.09%
Manteio Capital LLC 15,067$65,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders